| Diagnostics for SARS-CoV-2 infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Nature materials 20 (5), 593-605, 2021 | 854 | 2021 |
| Nanocarrier vaccines for SARS-CoV-2 J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Advanced Drug Delivery Reviews 171, 215-239, 2021 | 103 | 2021 |
| A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Journal of Neuroimmune Pharmacology 16 (2), 270-288, 2021 | 52 | 2021 |
| Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection MU Nayan, B Sillman, M Hasan, S Deodhar, S Das, A Sultana, NTH Le, ... Advanced Drug Delivery Reviews, 115009, 2023 | 25 | 2023 |
| Chronic Hepatitis B Infection: New Approaches towards Cure M Ogunnaike, S Das, SS Raut, A Sultana, MU Nayan, M Ganesan, ... Biomolecules 13 (8), 1208, 2023 | 19 | 2023 |
| The immunopathobiology of SARS-CoV-2 infection M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ... FEMS Microbiology Reviews 45 (6), fuab035, 2021 | 16 | 2021 |
| An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression S Das, W Wang, M Ganesan, F Fonseca-Lanza, DA Cobb, G Bybee, ... Science Advances 8 (51), eade9582, 2022 | 13 | 2022 |
| Pharmacotherapeutics of SARS-CoV-2 infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Journal of Neuroimmune Pharmacology 16 (1), 12-37, 2021 | 12 | 2021 |
| Development of an extended action fostemsavir lipid nanoparticle F Islam, S Das, M Ashaduzzaman, B Sillman, P Yeapuri, MU Nayan, ... Communications biology 7 (1), 917, 2024 | | 2024 |
| Development of Long-Acting Antiviral and Antimicrobial Prodrug Nanoformulations S Das | | 2024 |
| Synthesis and Characterization of a Long-Acting Tenofovir ProTide Nanoformulation FG Fonseca, S Das, D Cobb, MU Nayan, HE Gendelman, B Edagwa | | 2021 |